GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 78 filers reported holding GENERATION BIO CO in Q3 2023. The put-call ratio across all filers is 2.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,639 | -31.1% | 18,902 | 0.0% | 0.00% | – |
| Q2 2023 | $103,961 | +20.4% | 18,902 | -5.8% | 0.00% | – |
| Q1 2023 | $86,323 | +9.4% | 20,075 | 0.0% | 0.00% | – |
| Q4 2022 | $78,895 | -26.0% | 20,075 | 0.0% | 0.00% | – |
| Q3 2022 | $106,598 | -8.1% | 20,075 | +13.9% | 0.00% | – |
| Q2 2022 | $116,000 | +0.9% | 17,627 | +12.2% | 0.00% | – |
| Q1 2022 | $115,000 | +3.6% | 15,710 | 0.0% | 0.00% | – |
| Q4 2021 | $111,000 | -74.4% | 15,710 | -9.0% | 0.00% | -100.0% |
| Q3 2021 | $433,000 | -6.7% | 17,258 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $464,000 | -7.2% | 17,258 | -1.9% | 0.00% | 0.0% |
| Q1 2021 | $500,000 | – | 17,586 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
| Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
| HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
| Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
| PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
| BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
| Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
| Corton Capital Inc. | 15,493 | $102,000 | 0.10% |